Sean Thomas Mullen
Known title: Chief Growth OfficerCIK: 0002034388
Associated companies
Transaction History
| AMTM | ▲ Buy | Option Exercise | 9,072 | — | 5/6/2026 | View on chart |
| AMTM | ▼ Sell | Tax Withholding | 2,762 | $69K | 5/6/2026 | View on chart |
| AMTM | ▲ Buy | Option Exercise | 9,298 | — | 12/17/2025 | View on chart |
| AMTM | ▼ Sell | Tax Withholding | 4,194 | $120K | 12/17/2025 | View on chart |
| AMTM | ▲ Buy | Grant | 17,817 | $0 | 11/17/2025 | View on chart |
| AMTM | ▲ Buy | Option Exercise | 4,838 | — | 11/6/2025 | View on chart |
| AMTM | ▼ Sell | Tax Withholding | 1,621 | $35K | 11/6/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Amentum Faces Mixed Market Reaction After Deal and Analyst Upgrade
Amentum recently secured a preferred supplier role on a $2.8 billion Sellafield nuclear waste deal, which lifted the stock but also triggered a 5.5 % pullback. BNP Paribas upgraded the company to neutral, cutting its price target to $20, while analysts noted the firm’s focus on margin quality over revenue growth. The move comes amid a broader market rally for government‑consulting names, with Amentum’s shares showing a support rejection and a volume spike at the $20 level.
Amentum Faces Mixed Market Reaction After Deal and Analyst Upgrade. Amentum recently secured a preferred supplier role on a $2.8 billion Sellafield nuclear waste deal, which lifted the stock but also triggered a 5.5 % pullback. BNP Paribas upgraded the company to neutral, cutting its price target to $20, while analysts noted the firm’s focus on margin quality over revenue growth. The move comes amid a broader market rally for government‑consulting names, with Amentum’s shares showing a support rejection and a volume spike at the $20 level.